Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 158

1.

[Detection of isocitrate dehydrogenase 1 gene mutation in 205 AML patients and its clinical significance].

Shang Z, Wang D, Xiao M, Geng Z, Wang HX, Wang J, Xu YL, Li TJ, Zhou JF, Li CR.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2012 Dec;20(6):1307-11. Chinese.

PMID:
23257422
2.

[Mutation of isocitrate dehydrogenase 2 (IDH2) gene in Chinese AML patients and its clinical significance].

Shang Z, Wang D, Xiao M, Wang J, Li TJ, Zhao YC, Li CR, Zhou JF.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2013 Jun;21(3):607-12. doi: 10.7534/j.issn.1009-2137.2013.03.014. Chinese.

PMID:
23815907
3.

[Analysis of IDH1 and IDH2 mutations in patients with acute myeloid leukemia].

Jia ZX, Zhou M, Chao HY, Lu XZ, Zhang R, Cen L, Xiao R, Jiang NK.

Zhonghua Xue Ye Xue Za Zhi. 2012 May;33(5):397-401. Chinese.

PMID:
22781800
4.

Molecular alterations of isocitrate dehydrogenase 1 and 2 (IDH1 and IDH2) metabolic genes and additional genetic mutations in newly diagnosed acute myeloid leukemia patients.

Chotirat S, Thongnoppakhun W, Promsuwicha O, Boonthimat C, Auewarakul CU.

J Hematol Oncol. 2012 Mar 7;5:5. doi: 10.1186/1756-8722-5-5.

5.

[Clinical characteristics of newly diagnosed acute myeloid leukemia patients with NPM1 mutation].

Wei H, Zhang YQ, Lin D, Wang Y, Zhou CL, Liu BC, Li W, Rao Q, Wang M, Mi YC, Wang JX.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2014 Feb;22(1):11-5. doi: 10.7534/j.issn.1009-2137.2014.01.003. Chinese.

PMID:
24598642
6.

IDH1 and IDH2 mutations are frequent genetic alterations in acute myeloid leukemia and confer adverse prognosis in cytogenetically normal acute myeloid leukemia with NPM1 mutation without FLT3 internal tandem duplication.

Paschka P, Schlenk RF, Gaidzik VI, Habdank M, Krönke J, Bullinger L, Späth D, Kayser S, Zucknick M, Götze K, Horst HA, Germing U, Döhner H, Döhner K.

J Clin Oncol. 2010 Aug 1;28(22):3636-43. doi: 10.1200/JCO.2010.28.3762. Epub 2010 Jun 21.

7.

[Clinical characteristics in adult acute myeloid leukemia with isocitrate dehydrogenase gene mutation].

Wang RX, Wu DP, Chen SN, He J, Xu Y, Wang XL, Yin J, Tian H, Tian XP, Sun AN.

Zhonghua Yi Xue Za Zhi. 2013 Mar 12;93(10):751-5. Chinese.

PMID:
23755812
8.

IDH1 and IDH2 gene mutations identify novel molecular subsets within de novo cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study.

Marcucci G, Maharry K, Wu YZ, Radmacher MD, Mrózek K, Margeson D, Holland KB, Whitman SP, Becker H, Schwind S, Metzeler KH, Powell BL, Carter TH, Kolitz JE, Wetzler M, Carroll AJ, Baer MR, Caligiuri MA, Larson RA, Bloomfield CD.

J Clin Oncol. 2010 May 10;28(14):2348-55. doi: 10.1200/JCO.2009.27.3730. Epub 2010 Apr 5.

9.

Impact of IDH1 R132 mutations and an IDH1 single nucleotide polymorphism in cytogenetically normal acute myeloid leukemia: SNP rs11554137 is an adverse prognostic factor.

Wagner K, Damm F, Göhring G, Görlich K, Heuser M, Schäfer I, Ottmann O, Lübbert M, Heit W, Kanz L, Schlimok G, Raghavachar AA, Fiedler W, Kirchner HH, Brugger W, Zucknick M, Schlegelberger B, Heil G, Ganser A, Krauter J.

J Clin Oncol. 2010 May 10;28(14):2356-64. doi: 10.1200/JCO.2009.27.6899. Epub 2010 Apr 5.

10.

[IDH1 Gene Mutation and Its Clinical Significance in patients with Acute Myeloid Leukemia].

Wei JF, Qiu HY, Chen GH, Wang Y, Chen Z, Liu HJ, Mao JP, Jia T, Xue LG, Cai ZM, Zhu YX, Zhao LD.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2015 Oct;23(5):1252-7. doi: 10.7534/j.issn.1009-2137.2015.05.006. Chinese.

PMID:
26524018
11.

[C-kit, NPM1 and FLT3 gene mutation patterns and their prognostic significance in 656 Chinese patients with acute myeloid leukemia].

Ding ZX, Shen HJ, Miao JC, Chen SN, Qiu QC, Qi XF, Jin ZM, Wu DP, He J.

Zhonghua Xue Ye Xue Za Zhi. 2012 Oct;33(10):829-34. Chinese.

PMID:
23384905
12.

Acute myeloid leukemia with IDH1 or IDH2 mutation: frequency and clinicopathologic features.

Patel KP, Ravandi F, Ma D, Paladugu A, Barkoh BA, Medeiros LJ, Luthra R.

Am J Clin Pathol. 2011 Jan;135(1):35-45. doi: 10.1309/AJCPD7NR2RMNQDVF.

13.

[Detection of NPM1, FLT3 and C-KIT mutations in acute myeloid leukemia and their prognostic analysis].

Li L, Lyu XD, Mi RH, Ding J, Chen L, Wang Q, Yin QS, Hu JY, Fan RH, Wei XD.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2013 Jun;21(3):601-6. doi: 10.7534/j.issn.1009-2137.2013.03.013. Chinese.

PMID:
23815906
14.

[Isocitrate dehydrogenase gene mutations in acute myeloid leukemia].

Zhou XJ, Zhang SJ, Qiao C, Shen YF, Li JY.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2011 Aug;19(4):902-6. Chinese.

PMID:
21867611
15.

[Clinical significance of IDH1 and IDH2 mutations in patients with acute myeloid leukemia].

Mi RH, Lu XD, Wei XD, Fan RH, Yin QS, Hu JY, Wang Q, Song YP.

Zhonghua Xue Ye Xue Za Zhi. 2011 Sep;32(9):610-3. Chinese.

PMID:
22338155
16.

Adverse impact of IDH1 and IDH2 mutations in primary AML: experience of the Spanish CETLAM group.

Nomdedéu J, Hoyos M, Carricondo M, Esteve J, Bussaglia E, Estivill C, Ribera JM, Duarte R, Salamero O, Gallardo D, Pedro C, Aventin A, Brunet S, Sierra J.

Leuk Res. 2012 Aug;36(8):990-7. doi: 10.1016/j.leukres.2012.03.019. Epub 2012 Apr 19.

PMID:
22520341
17.

The prognostic significance of IDH1 mutations in younger adult patients with acute myeloid leukemia is dependent on FLT3/ITD status.

Green CL, Evans CM, Hills RK, Burnett AK, Linch DC, Gale RE.

Blood. 2010 Oct 14;116(15):2779-82. doi: 10.1182/blood-2010-02-270926. Epub 2010 Jul 22.

18.

The Frequency and clinical significance of IDH1 mutations in Chinese acute myeloid leukemia patients.

Guan L, Gao L, Wang L, Li M, Yin Y, Yu L, Gao C.

PLoS One. 2013 Dec 20;8(12):e83334. doi: 10.1371/journal.pone.0083334. eCollection 2013.

19.

High IDH1 expression is associated with a poor prognosis in cytogenetically normal acute myeloid leukemia.

Ma QL, Wang JH, Wang YG, Hu C, Mu QT, Yu MX, Wang L, Wang DM, Yang M, Yin XF, Chen FF, Lu SS, Chen J, Zhu ZJ, Chen SJ, Jin J.

Int J Cancer. 2015 Sep 1;137(5):1058-65. doi: 10.1002/ijc.29395. Epub 2015 Jan 13.

PMID:
25523507
20.

Prognostic value of IDH1 mutations identified with PCR-RFLP assay in acute myeloid leukemia patients.

Elsayed GM, Nassar HR, Zaher A, Elnoshokaty EH, Moneer MM.

J Egypt Natl Canc Inst. 2014 Mar;26(1):43-9. doi: 10.1016/j.jnci.2013.11.001. Epub 2013 Nov 27.

Items per page

Supplemental Content

Write to the Help Desk